ʻO ka lāʻau lapaʻau waha COVID-19 hou e hōʻike ana i ka 100% hoʻōla

A HOLD FreeRelease | eTurboNews | eTN
i kakauia ma Linda Hohnholz

Ua hoʻolaha ʻo Golden Biotechnology Corp. he hui biopharmaceutical Taiwanese, ua loaʻa i kāna Phase 2 COVID-19 ka hoʻāʻo ʻana no ka lāʻau Antroquinonol (HOCENA®) hou i ka 100% o nā hopena hoʻihoʻi o kāna ana hopena mua i ka hale maʻi maʻi, haʻahaʻa me nā maʻi koʻikoʻi ICU.

E like me ka hoʻolālā, e hoʻouna ʻo GoldenBiotech i ka hōʻike hoʻāʻo hoʻokolohua hope loa a me nā palapala R&D pili i ka US FDA e noi ai no ka mana hoʻohana pilikia (EUA) no Antroquinonol (HOCENA®).          

ʻO kēia hoʻāʻo he Phase 2 randomized, double-blind, placebo-controlled study no ka loiloi ʻana i ka palekana a me ka pono o ka Antroquinonol i nā maʻi maʻi maʻi me ka maʻi pneumonia haʻahaʻa ma muli o COVID-19 (Coronavirus SARS-CoV-2 maʻi). ʻOiaʻiʻo, ua komo pū ka hoʻokolokolo i nā maʻi maʻi ICU e pono ai ke kākoʻo oxygen. Ma hope o ka pau ʻana o nā loiloi screening āpau a me ka hālāwai ʻana i nā koina kūpono, e loaʻa nā mea maʻi i ka 100mg o Antroquinonol a i ʻole placebo ʻelua manawa i ka lā no 14 mau lā i hui pū ʻia me Standard of Care (SoC) therapy no nā kulekele SoC kūloko. Ua hoʻopau ka hoʻāʻo ʻana no nā mea maʻi 124 ma USA, Peru a me Argentina kahi e ulu nui ai ka maʻi maʻi maʻi hou me nā ʻano like ʻole SARS-CoV-2.

Ua hōʻike ʻia ka ʻikepili hoʻokolohua lapaʻau:

1. ʻO ke ana o ka hopena mua: hoʻihoʻi i ka ratio [Manawa: 14 mau lā] ʻO ka hapa o nā maʻi e ola ana a ʻaʻohe o ka hanu ʻana (e laʻa, ʻaʻohe pono o ka hoʻoheheʻe mechanical invasive, non-invasive ventilation, high flow oxygen, a i ʻole ECMO) ma ʻO ka lā 14. Ka hopena: Ma ka hui Antroquinonol, ʻo 97.9% ka lākiō hoʻōla i ka lā 14 kipa. Eia kekahi, ʻaʻohe make a i ʻole ka hanu hanu i ʻike ʻia ma ka hui Antroquinonol i ka lā 28 kipa me ka lākiō hoʻōla o 100%.

2. Nā ana o ka hopena lua:(a) Ka lōʻihi o ka noho ʻana o ka ICU: Ka hopena: ʻO ka lōʻihi o ka noho ʻana o ka ICU ma ka hui Antroquinonol he 9.5 mau lā ʻoi aku ka pōkole ma mua o kēlā ma ka hui placebo. (b) Ka lōʻihi o ka hale maʻi [ Time Frame: 28 lā]: manawa no ka hoʻokuʻu ʻana o ka mea maʻi. Ka hopena: ʻO ka lōʻihi o ka manawa o ka hale maʻi he 4 mau lā ma ka hui Antroquinonol. : Ka helu hoʻololi maʻi maʻi e like me ke ana ʻana e ka "WHO COVID-2 Clinical Improvement Ordinal Scale". Hua: ʻO ka manawa waena o ka helu 28 ma "WHO COVID-19 Clinical Improvement Ordinal Scale" he 0 mau lā ma ka hui antroquinonol.(d) Ka manawa no ka hoʻomaʻemaʻe virological [ Time Frame: 19 lā]: ana ʻia e like me nā lā aʻo mai ka hoʻomaka ʻana o ka mālama ʻana a hiki i ka hoʻāʻo mua ʻana o SARS-CoV-29 PCR. Ka hopena: ʻO ka manawa waena o ka hoʻomaʻemaʻe virological he 28 mau lā i ka hui Antroquinonol.

Ma ka loiloi palekana, ua hōʻike ka ʻikepili i hōʻike ʻia ʻo Antroquinonol i ka hoʻomanawanui maikaʻi a me nā hopena palekana.

<

No ka mea kākau

Linda Hohnholz

Lunahooponopono no eTurboNews ma ka eTN HQ.

kakau
E hoʻomaopopo i
malihini
0 Comments
Nā ʻōlelo Hoʻohui Kūʻai
E nānā i nā ʻōlelo āpau
0
E aloha nui i kou mau manaʻo, e ʻoluʻolu.x
()
x
Kaʻana like i...